Why the study?
Cardiovascular disease and COPD frequently coexist and increase adverse outcomes, yet the dysfunction of metabolically active epicardial and airway-associated/peribronchial adipose tissue depots has been studied largely in isolation.
Population
Patients with coexisting cardiovascular disease and chronic obstructive pulmonary disease
Design
Review
Answers are grounded in this paper and cite their sources.
Review reveals adipose tissue dysfunction and inflammation as a shared pathological hub in cardiopulmonary comorbidity, highlighting therapeutic targets for coexisting heart and lung disease.
Cardiovascular disease (CVD) and chronic obstructive pulmonary disease (COPD) often coexist, and their combination markedly increases the risk of adverse outcomes. Epicardial adipose tissue (EAT) and airway-associated/peribronchial adipose tissue (AAT/PBAT) are metabolically active periorgan depots, yet their dysfunction has been studied largely in isolation. Under shared risk factors (smoking, obesity, hypoxia, and physical inactivity), both depots undergo a profound immunometabolic switch from protective metabolic neighbors to pathogenic secretory organs that promote local inflammation and structural remodeling. This review synthesizes current evidence to propose a novel conceptual framework: the adipose-inflammatory interaction network, a unifying pathological hub for cardiopulmonary comorbidity. At the core of this network lies a shared axis of chronic inflammation and metabolic dysregulation, in which each process can amplify the other. Built upon this foundation, paracrine signals from EAT remodel the myocardium and coronary arteries, whereas an analogous paracrine role for AAT/PBAT in the airways is proposed but, in the absence of human COPD data, remains unproven. Superimposed on these layers, circulating adipokines, extracellular vesicle-derived miRNAs, and neuro-immune and neuro-humoral circuits amplify local dysfunction into a systemic, cross-organ state. By mapping this multilevel system, we identify key nodes where metabolic and inflammatory signals converge and position the two depots as sensors and amplifiers of a shared cardiopulmonary inflammatory burden; direct signaling between EAT and AAT/PBAT has not been demonstrated. Epidemiologically, COPD exacerbations drive acute cardiovascular events through acute thromboinflammation acting on a chronic adipose–inflammatory substrate, whereas reverse causation remains unproven. We conclude that this framework clarifies how shared risk factors translate into concomitant cardiopulmonary damage and highlights directions for future research.
No takes yet. Share an insight, caveat, or question.
Dong et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: